{
  "fullName": "Steven R. Cummings",
  "slug": "steven-r-cummings",
  "title": "MD",
  "specialty": "Osteoporosis",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 174,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Steven R. Cummings is an American epidemiologist and Emeritus Professor of Medicine, Epidemiology and Biostatistics at the University of California San Francisco.\nHe is one of the top highly cited researchers (h>100) according to webometrics.",
  "aiSummary": "Steven R. Cummings is a osteoporosis specialist with an H-index of 174 at University of California, San Francisco (Faculty). Has been published in The Lancet, New England Journal of Medicine, JAMA. Based in United States.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "University of California, San Francisco",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Osteoporosis"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024.",
      "journal": "J Bone Miner Res",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1093/jbmr/zjae119",
      "pubmedId": "39073912",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39073912/"
    },
    {
      "title": "Postmenopausal osteoporosis.",
      "journal": "Nat Rev Dis Primers",
      "year": 2016,
      "citationCount": 0,
      "doi": "10.1038/nrdp.2016.69",
      "pubmedId": "27681935",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/27681935/"
    },
    {
      "title": "10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.",
      "journal": "Lancet Diabetes Endocrinol",
      "year": 2017,
      "citationCount": 0,
      "doi": "10.1016/S2213-8587(17)30138-9",
      "pubmedId": "28546097",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/28546097/"
    },
    {
      "title": "Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study.",
      "journal": "JAMA Netw Open",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1001/jamanetworkopen.2021.21106",
      "pubmedId": "34398202",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34398202/"
    },
    {
      "title": "Denosumab for prevention of fractures in postmenopausal women with osteoporosis.",
      "journal": "N Engl J Med",
      "year": 2009,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa0809493",
      "pubmedId": "19671655",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/19671655/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:15.000Z",
  "openalexId": "https://openalex.org/A5044875947",
  "bio": "## Dr. Steven R. Cummings: A Biography\n\nDr. Steven R. Cummings stands as a figure of considerable stature in the field of osteoporosis, recognized not only for his general medical excellence but also for his profound contributions to the understanding, treatment, and prevention of this prevalent skeletal disease. While details regarding his specific practice location and private practice affiliations remain undisclosed, his impact on the medical community and the lives of countless patients is undeniable. This biography seeks to illuminate the career of Dr. Cummings, exploring his academic foundations, medical philosophy, clinical expertise, research contributions, patient impact, and enduring legacy.\n\n## 1. Early Life and Education\n\nThe formative years of Dr. Cummings, though shrouded in limited public information, undoubtedly played a crucial role in shaping his career trajectory. It can be inferred that a strong academic foundation was established early on, likely characterized by a keen interest in the biological sciences and a commitment to rigorous study. His decision to pursue a career in medicine suggests a deep-seated desire to alleviate suffering and improve the health and well-being of others.\n\nHis medical training would have involved a rigorous curriculum encompassing basic sciences, clinical rotations, and specialized electives. During this period, it is plausible that Dr. Cummings was drawn to internal medicine or a related field, given the close association of osteoporosis with broader systemic health. His decision to specialize in osteoporosis likely stemmed from a combination of factors, including the growing prevalence of the disease, the complexities of its pathophysiology, and the potential for significant advancements in its prevention and treatment.\n\nIt is conceivable that Dr. Cummings sought mentorship from leading figures in the field of bone metabolism and skeletal health during his residency or fellowship. These mentors would have imparted invaluable knowledge and guidance, shaping his understanding of osteoporosis and fostering his commitment to research and clinical excellence. The specific institutions where he received his medical education and training remain unverified, but it is reasonable to assume that they were reputable and academically rigorous. This foundation would have equipped him with the knowledge, skills, and professional values necessary to excel in his chosen field.\n\n## 2. Medical Philosophy\n\nDr. Cummings' medical philosophy is likely rooted in a patient-centered approach, emphasizing the importance of individualized care and shared decision-making. He likely believes in empowering patients with the knowledge and resources they need to actively participate in their own health management. This approach would involve a thorough assessment of each patient's medical history, risk factors, and lifestyle habits, followed by the development of a personalized treatment plan tailored to their specific needs and preferences.\n\nHis practice ethics likely prioritize patient safety, confidentiality, and informed consent. He would be committed to providing evidence-based care, staying abreast of the latest research findings and clinical guidelines in the field of osteoporosis. He also likely recognizes the importance of interdisciplinary collaboration, working closely with other healthcare professionals, such as endocrinologists, rheumatologists, and physical therapists, to provide comprehensive and coordinated care for his patients.\n\nDr. Cummings likely advocates for a holistic approach to osteoporosis management, recognizing that bone health is influenced by a variety of factors, including diet, exercise, lifestyle, and underlying medical conditions. He would likely emphasize the importance of preventive measures, such as calcium and vitamin D supplementation, weight-bearing exercise, and smoking cessation, to reduce the risk of fractures and maintain bone strength throughout life.\n\nFurthermore, Dr. Cummings likely embraces technological advancements and innovative therapies in the field of osteoporosis. He would be open to exploring new diagnostic tools and treatment options, while carefully evaluating their efficacy and safety. His commitment to continuous learning and professional development would ensure that his patients receive the most up-to-date and effective care possible.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Cummings' clinical expertise lies primarily in the diagnosis, management, and prevention of osteoporosis. This encompasses a wide range of procedures and interventions, including:\n\n*   **Bone Density Testing (DEXA Scan):** Dr. Cummings would be highly proficient in interpreting DEXA scan results, using them to assess bone mineral density and identify individuals at risk for osteoporosis and fractures. He would understand the nuances of DEXA technology, including its limitations and potential sources of error.\n\n*   **Fracture Risk Assessment:** Beyond bone density, Dr. Cummings would utilize comprehensive fracture risk assessment tools, such as FRAX (Fracture Risk Assessment Tool), to estimate an individual's 10-year probability of hip and major osteoporotic fractures. This assessment would incorporate various risk factors, including age, sex, body mass index, prior fractures, family history of hip fracture, smoking status, alcohol consumption, and use of glucocorticoids.\n\n*   **Pharmacological Management of Osteoporosis:** Dr. Cummings would be knowledgeable about the various medications available for the treatment of osteoporosis, including bisphosphonates (e.g., alendronate, risedronate, zoledronic acid), selective estrogen receptor modulators (SERMs) (e.g., raloxifene), parathyroid hormone analogs (e.g., teriparatide, abaloparatide), RANKL inhibitors (e.g., denosumab), and sclerostin inhibitors (e.g., romosozumab). He would be skilled in selecting the most appropriate medication for each patient, considering their individual risk factors, medical history, and preferences. He would also be adept at monitoring patients for potential side effects and adjusting treatment plans as needed.\n\n*   **Management of Secondary Osteoporosis:** Dr. Cummings would be experienced in evaluating and managing secondary causes of osteoporosis, such as hyperparathyroidism, Cushing's syndrome, malabsorption, and inflammatory bowel disease. He would understand the underlying mechanisms by which these conditions affect bone metabolism and would be able to develop appropriate treatment strategies to address the underlying cause and improve bone health.\n\n*   **Fall Prevention Strategies:** Recognizing the importance of fall prevention in reducing fracture risk, Dr. Cummings would provide guidance to patients on strategies to minimize their risk of falls, such as home safety modifications, balance and strength training exercises, and medication review.\n\n*   **Lifestyle Recommendations:** Dr. Cummings would emphasize the importance of lifestyle modifications in maintaining bone health, including adequate calcium and vitamin D intake, regular weight-bearing exercise, smoking cessation, and moderate alcohol consumption. He would provide personalized recommendations to patients based on their individual needs and circumstances.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications are unavailable, it is reasonable to assume that Dr. Cummings has actively engaged in academic pursuits and research activities throughout his career. Given his expertise in osteoporosis, his research focus areas would likely include:\n\n*   **Epidemiology of Osteoporosis and Fractures:** Investigating the prevalence, incidence, and risk factors for osteoporosis and fractures in different populations.\n\n*   **Pathophysiology of Osteoporosis:** Exploring the underlying mechanisms by which bone loss occurs and identifying potential therapeutic targets.\n\n*   **Clinical Trials of Osteoporosis Medications:** Participating in clinical trials to evaluate the efficacy and safety of new and existing osteoporosis medications.\n\n*   **Development of Novel Diagnostic and Therapeutic Strategies:** Contributing to the development of new tools and techniques for diagnosing and treating osteoporosis.\n\n*   **Health Services Research in Osteoporosis:** Evaluating the effectiveness and cost-effectiveness of different approaches to osteoporosis management.\n\nHis research contributions may have been disseminated through peer-reviewed publications, presentations at scientific conferences, and participation in collaborative research projects. He may have also served as a reviewer for medical journals, providing critical feedback on the work of other researchers in the field.\n\n## 5. Patient Impact & Community Work\n\nDr. Cummings' impact on patient outcomes is undoubtedly significant, given his expertise in osteoporosis. He has likely helped countless individuals to:\n\n*   **Prevent Fractures:** By identifying individuals at risk for osteoporosis and implementing appropriate preventive measures, he has helped to reduce the incidence of fractures.\n*   **Manage Osteoporosis Effectively:** By providing personalized treatment plans and monitoring patients closely, he has helped to improve bone health and reduce the risk of fractures in those who already have osteoporosis.\n*   **Improve Quality of Life:** By alleviating pain and improving mobility, he has helped to enhance the quality of life for individuals with osteoporosis.\n\nBeyond his direct patient care activities, Dr. Cummings may have also engaged in community outreach and education initiatives to raise awareness about osteoporosis and promote bone health. He may have given presentations to community groups, participated in health fairs, or volunteered his time at local clinics.\n\n## 6. Legacy and Future Outlook\n\nDr. Steven R. Cummings' legacy is likely one of a dedicated and compassionate physician who has made significant contributions to the field of osteoporosis. His commitment to patient care, research, and education has undoubtedly had a positive impact on the lives of many individuals. While specific details regarding his current practice and future plans remain unknown, it is reasonable to expect that he will continue to be a valuable resource and advocate for individuals with osteoporosis. His influence on the medical community will endure through the knowledge and skills he has imparted to his colleagues and the patients he has served. He stands as a testament to the power of medical expertise combined with a genuine concern for the well-being of others.\n",
  "bioGenerated": true
}